Reaction profile

The FDA adverse-event record for adrenal gland tumour

Name: Adrenal gland tumour - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

39 FDA reports name adrenal gland tumour, a lower-volume reaction in the CVM extract (VeDDRA 2927). Plate stamps and neighbourhood peers follow.

#1856 of 2,481
by report volume (all reactions): 39
reports citing this reaction: 51.3%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Adrenal gland tumour has 39 reports now versus 36 in that prior snapshot: 3 more (8.3%).

Report change: +3
Death-coded reports: +0
Death-coded share: −4.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Adrenal gland tumour changes

FDA AER · VeDDRA plate

Code 2927 VOL-TRACE

VOL-TRACE · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 39 reports
DEATH-HOT 51.3%
MID-PACK #1856/2481
PHOTO-FINISH Adaptor, missing
SPECIES-DOG Dog · 39
DRUG-LEAD Bedinvetmab · 16
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Adaptor, missing (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Adrenal gland tumour

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Adrenal gland tumour

Adrenal gland tumour: high death-coded share in the FDA AER plate

Signature read: Adrenal gland tumour's 51.3% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 39 named reports in the openFDA extract. Death-coded share is upper-third: 20 of 39 reports (51.3% of named reports). Nearest volume peer: Adaptor, missing (±0 reports). Lead species Dog (39). Lead co-reported drug Bedinvetmab (16).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 39

Breeds Most Affected

Retriever - Labrador 3

Terrier - West Highland White 3

Dog (unknown) 3

Lhasa Apso 3

Retriever - Golden 3

Bulldog - English 2

Bichon Frise 2

Shih Tzu 2

Beagle 2

Terrier - Boston 1

Associated Drugs

Bedinvetmab 16

Trilostane 16

Maropitant Citrate 8

Gabapentin 8

Carprofen 6

Grapiprant 5

Oclacitinib Maleate 4

Omeprazole 4

Doxycycline 4

Prednisone 4

Atipamezole 3

Enrofloxacin 3

Famotidine 2

Propofol 2

Pyrantel Pamoate;Sarolaner 2

Trazodone 2

Dexmedetomidine 2

Torbugesic 2

Prednisolone Tablets 2

Blood Transfusion 2

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Adrenal gland tumour (#1856 of 2,481 by report volume); death-coded 51.3%. PlainBreed reaction plate · death-coded share stamp 51.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →